Epithalon + Follistatin Stack vs MK-677 (Ibutamoren)
Overview
Epithalon + Follistatin Stack and MK-677 (Ibutamoren) are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Epithalon + Follistatin Stack and MK-677 (Ibutamoren) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Epithalon + Follistatin Stack | MK-677 (Ibutamoren) | |
|---|---|---|
| Category | Performance & Growth | Performance & Growth |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | Research use only |
| Typical dosage | Protocol varies | 10-25 mg |
| Frequency | cycled | daily |
| Reported benefits | Synergistic anti-aging and muscle building effects | Increased appetite, muscle growth, improved sleep, bone density enhancement |
| Reported side effects | Monitor individually | Increased appetite, water retention, elevated blood sugar, potential insulin resistance |
Key differences
Primary use. Epithalon + Follistatin Stack is categorised under Performance & Growth, while MK-677 (Ibutamoren) falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Epithalon + Follistatin Stack: not FDA-approved; compounding permitted with a prescription as of April 2026. MK-677 (Ibutamoren): not FDA-approved; treated as a research compound.
Dosing. Epithalon + Follistatin Stack is typically dosed at Protocol varies (cycled). MK-677 (Ibutamoren) is typically dosed at 10-25 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Epithalon + Follistatin Stack and MK-677 (Ibutamoren) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Epithalon + Follistatin Stack and MK-677 (Ibutamoren)?
- Epithalon + Follistatin Stack and MK-677 (Ibutamoren) are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. Epithalon + Follistatin Stack is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas MK-677 (Ibutamoren) is not FDA-approved; generally classified as a research compound.
- What is Epithalon + Follistatin Stack used for?
- Anti-aging performance combo.
- What is MK-677 (Ibutamoren) used for?
- Oral GH secretagogue.
- Can you take Epithalon + Follistatin Stack and MK-677 (Ibutamoren) together?
- Some users combine peptides within a single protocol, but stacking Epithalon + Follistatin Stack and MK-677 (Ibutamoren) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Epithalon + Follistatin Stack or MK-677 (Ibutamoren) FDA-approved?
- Epithalon + Follistatin Stack is not FDA-approved; compounding permitted with a prescription (as of April 2026). MK-677 (Ibutamoren) is not FDA-approved; generally classified as a research compound.
Read the full articles
- Epithalon + Follistatin Stack — full monograph: mechanism, research, dosing & references
- MK-677 (Ibutamoren) — full monograph: mechanism, research, dosing & references